Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

13.44
Delayed Data
As of May 22
 +0.18 / +1.36%
Today’s Change
7.31
Today|||52-Week Range
14.07
+61.93%
Year-to-Date

Today’s Trading

Previous close13.26
Today’s open13.26
Day’s range13.23 - 13.52
Volume860,943
Average volume (3 months)763,928
Market cap$633.3M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-57.03%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio19.1
Price/Sales2.87
Price/Book7.99

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.04-0.68%
INFIInfinity Pharmaceuti...-0.02-0.16%
OREXOrexigen Therapeutic...+0.01+0.20%
NWBONorthwest Biotherape...-0.08-0.99%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers